Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Toxicity;Chemical”

332 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 332 results

Not applicableUnknownNCT05892146
What this trial is testing

Strategy Therapy on Cancer Therapy-Related Cardiac Dysfunction

Who this might be right for
Chemotherapeutic ToxicityCardiotoxicityHeart Failure+2 more
National Cheng-Kung University Hospital 100
Testing effectiveness (Phase 2)UnknownNCT01965275
What this trial is testing

High-Dose,Pulsatile Erlotinib/Gefitinib for Advanced NSCLC Patients After Failure of Standard Dose EGFR-TKIs

Who this might be right for
Self EfficacyDrug Toxicity
Anhui Medical University 20
Post-approval studies (Phase 4)Study completedNCT03461445
What this trial is testing

Effect of Tacrolimus Formulation on Neurological Side Effects in Older Kidney Transplant Recipients

Who this might be right for
Kidney Transplant; ComplicationsToxicityDrug Toxicity+1 more
University of California, Davis 64
Not applicableLooking for participantsNCT06270667
What this trial is testing

Effects of Exercise Training in Survivors of Lymphoma

Who this might be right for
LymphomaPhysical ExerciseCardiotoxicity+2 more
Norwegian School of Sport Sciences 280
Not applicableStudy completedNCT06817044
What this trial is testing

Optimising Screening for the Cardiotoxic Effects of Cancer Therapy

Who this might be right for
Ventricular DysfunctionCardiotoxicityChemotherapeutic Toxicity
Barts & The London NHS Trust 80
Not applicableLooking for participantsNCT07456592
What this trial is testing

Development of an Aptamer-based Lateral Flow Device for Point-of-care Detection of Toxic Chinese Medicine Herbs (ALPTH Project)

Who this might be right for
Aconite Poisoning
The University of Hong Kong 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT04305145
What this trial is testing

Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis

Who this might be right for
Melanoma Stage IIIMelanoma Stage IVSkin Cancer Stage III+4 more
Massachusetts General Hospital 42
Post-approval studies (Phase 4)Ended earlyNCT03191201
What this trial is testing

A Double Blind Randomised Placebo-controlled Trial to Assess the Role of Iron Repletion in Glucose Homeostasis.

Who this might be right for
Iron-deficiencyIron ToxicityGlucose Metabolism Disorders (Including Diabetes Mellitus)+3 more
Prof Gérard WAEBER 32
Large-scale testing (Phase 3)Study completedNCT00296036
What this trial is testing

Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other Cancer

Who this might be right for
Breast CancerDrug/Agent Toxicity by Tissue/OrganUnspecified Adult Solid Tumor, Protocol Specific
Alliance for Clinical Trials in Oncology 137
Testing effectiveness (Phase 2)WithdrawnNCT00372723
What this trial is testing

Study of a Potential New Treatment for Patients With Toxic Epidermal Necrolysis (TEN)

Who this might be right for
Toxic Epidermal Necrolysis
Loyola University
Not applicableStudy completedNCT04690231
What this trial is testing

Apatinib + Ifosfamide and Etoposide for Relapsed or Refractory Osteosarcoma

Who this might be right for
Effect of DrugToxicity, DrugSecondary Resistance
Peking University People's Hospital 79
Large-scale testing (Phase 3)Study completedNCT00003600
What this trial is testing

Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy

Who this might be right for
AnemiaBreast CancerChronic Myeloproliferative Disorders+8 more
Alliance for Clinical Trials in Oncology 344
Early research (Phase 1)Study completedNCT00039481
What this trial is testing

Oblimersen Plus Combination Chemotherapy and Dexrazoxane in Treating Children and Adolescents With Relapsed or Refractory Solid Tumors

Who this might be right for
Cardiac ToxicityUnspecified Childhood Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 15
Large-scale testing (Phase 3)Study completedNCT04877067
What this trial is testing

Therapy of Toxic Optic Neuropathy Via Combination of Stem Cells With Electromagnetic Stimulation

Who this might be right for
Methanol PoisoningToxic Optic NeuropathyStem Cell Tyrosine Kinase 1 Y842X+1 more
Ankara Universitesi Teknokent 18
Post-approval studies (Phase 4)Study completedNCT05237492
What this trial is testing

The Influence of Tramadol on Platelet Function

Who this might be right for
Drug ToxicityPlatelet DysfunctionClotting Disorder
Medical University of Graz 33
Not applicableLooking for participantsNCT05652673
What this trial is testing

Safe Stop Ipilimumab-nivolumab (IPI-NIVO) Trial

Who this might be right for
Melanoma Stage IVMelanoma Stage IIIImmunotherapy+1 more
Erasmus Medical Center 80
Not applicableLooking for participantsNCT05921279
What this trial is testing

Understanding CARdiac Events in Breast Cancer

Who this might be right for
Breast CancerCardiotoxicityCardiomyopathies+3 more
National University of Ireland, Galway, Ireland 100
Post-approval studies (Phase 4)Study completedNCT04070469
What this trial is testing

Plasma Concentrations of Amoxicillin Administered in High-doses During the First Week of Treatment (MAX-AMOX)

Who this might be right for
Infection, Bacterial
University Hospital, Clermont-Ferrand 142
Early research (Phase 1)UnknownNCT00024310
What this trial is testing

Paclitaxel, Folic Acid, and Lometrexol in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganUnspecified Adult Solid Tumor, Protocol Specific
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07110662
What this trial is testing

New Therapeutic Target for Toxic Epidermal Necrolysis (TEN) Using Anti-CD38+ Monoclonal Antibodies.

Who this might be right for
Toxic Epidermal NecrolysisImmunotherapyCutaneous Adverse Drug Reactions (CADR)
Hospices Civils de Lyon 9
Load More Results